254 related articles for article (PubMed ID: 33653269)
1. A machine learning-based gene signature of response to the novel alkylating agent LP-184 distinguishes its potential tumor indications.
Kathad U; Kulkarni A; McDermott JR; Wegner J; Carr P; Biyani N; Modali R; Richard JP; Sharma P; Bhatia K
BMC Bioinformatics; 2021 Mar; 22(1):102. PubMed ID: 33653269
[TBL] [Abstract][Full Text] [Related]
2. The acylfulvene alkylating agent, LP-184, retains nanomolar potency in non-small cell lung cancer carrying otherwise therapy-refractory mutations.
Kulkarni A; McDermott JR; Kathad U; Modali R; Richard JP; Sharma P; Bhatia K
Oncotarget; 2021 Apr; 12(8):791-806. PubMed ID: 33889302
[TBL] [Abstract][Full Text] [Related]
3. Open source machine-learning algorithms for the prediction of optimal cancer drug therapies.
Huang C; Mezencev R; McDonald JF; Vannberg F
PLoS One; 2017; 12(10):e0186906. PubMed ID: 29073279
[TBL] [Abstract][Full Text] [Related]
4. Genome-wide analysis of three-way interplay among gene expression, cancer cell invasion and anti-cancer compound sensitivity.
Hsu YC; Chen HY; Yuan S; Yu SL; Lin CH; Wu G; Yang PC; Li KC
BMC Med; 2013 Apr; 11():106. PubMed ID: 23590835
[TBL] [Abstract][Full Text] [Related]
5. A radiomics approach to assess tumour-infiltrating CD8 cells and response to anti-PD-1 or anti-PD-L1 immunotherapy: an imaging biomarker, retrospective multicohort study.
Sun R; Limkin EJ; Vakalopoulou M; Dercle L; Champiat S; Han SR; Verlingue L; Brandao D; Lancia A; Ammari S; Hollebecque A; Scoazec JY; Marabelle A; Massard C; Soria JC; Robert C; Paragios N; Deutsch E; Ferté C
Lancet Oncol; 2018 Sep; 19(9):1180-1191. PubMed ID: 30120041
[TBL] [Abstract][Full Text] [Related]
6. Prediction of Chemosensitivity in Multiple Primary Cancer Patients Using Machine Learning.
Zhang X; Jang MI; Zheng Z; Gao A; Lin Z; Kim KY
Anticancer Res; 2021 May; 41(5):2419-2429. PubMed ID: 33952467
[TBL] [Abstract][Full Text] [Related]
7. Automatic discovery of 100-miRNA signature for cancer classification using ensemble feature selection.
Lopez-Rincon A; Martinez-Archundia M; Martinez-Ruiz GU; Schoenhuth A; Tonda A
BMC Bioinformatics; 2019 Sep; 20(1):480. PubMed ID: 31533612
[TBL] [Abstract][Full Text] [Related]
8. Application of Machine Learning in Developing a Novelty Five-Pseudogene Signature to Predict Prognosis of Head and Neck Squamous Cell Carcinoma: A New Aspect of "Junk Genes" in Biomedical Practice.
Xing L; Zhang X; Guo M; Zhang X; Liu F
DNA Cell Biol; 2020 Apr; 39(4):709-723. PubMed ID: 32045271
[TBL] [Abstract][Full Text] [Related]
9. Development of a prognostic composite cytokine signature based on the correlation with nivolumab clearance: translational PK/PD analysis in patients with renal cell carcinoma.
Wang R; Zheng J; Shao X; Ishii Y; Roy A; Bello A; Lee R; Zhang J; Wind-Rotolo M; Feng Y
J Immunother Cancer; 2019 Dec; 7(1):348. PubMed ID: 31829287
[TBL] [Abstract][Full Text] [Related]
10. Precise prediction of multiple anticancer drug efficacy using multi target regression and support vector regression analysis.
Brindha GR; Rishiikeshwer BS; Santhi B; Nakendraprasath K; Manikandan R; Gandomi AH
Comput Methods Programs Biomed; 2022 Sep; 224():107027. PubMed ID: 35914385
[TBL] [Abstract][Full Text] [Related]
11. Predicting chemosensitivity using drug perturbed gene dynamics.
Mannheimer JD; Prasad A; Gustafson DL
BMC Bioinformatics; 2021 Jan; 22(1):15. PubMed ID: 33413081
[TBL] [Abstract][Full Text] [Related]
12. Anticancer drug sensitivity prediction in cell lines from baseline gene expression through recursive feature selection.
Dong Z; Zhang N; Li C; Wang H; Fang Y; Wang J; Zheng X
BMC Cancer; 2015 Jun; 15():489. PubMed ID: 26121976
[TBL] [Abstract][Full Text] [Related]
13. Machine learning approach yields epigenetic biomarkers of food allergy: A novel 13-gene signature to diagnose clinical reactivity.
Alag A
PLoS One; 2019; 14(6):e0218253. PubMed ID: 31216310
[TBL] [Abstract][Full Text] [Related]
14. Preclinical Efficacy of LP-184, a Tumor Site Activated Synthetic Lethal Therapeutic, in Glioblastoma.
Lal B; Kulkarni A; McDermott J; Rais R; Alt J; Wu Y; Lopez-Bertoni H; Sall S; Kathad U; Zhou J; Slusher BS; Bhatia K; Laterra J
Clin Cancer Res; 2023 Oct; 29(20):4209-4218. PubMed ID: 37494541
[TBL] [Abstract][Full Text] [Related]
15. Gene signatures developed from patient tumor explants grown in nude mice to predict tumor response to 11 cytotoxic drugs.
Fiebig HH; Schüler J; Bausch N; Hofmann M; Metz T; Korrat A
Cancer Genomics Proteomics; 2007; 4(3):197-209. PubMed ID: 17878523
[TBL] [Abstract][Full Text] [Related]
16. Predicting Outcomes of Hormone and Chemotherapy in the Molecular Taxonomy of Breast Cancer International Consortium (METABRIC) Study by Biochemically-inspired Machine Learning.
Mucaki EJ; Baranova K; Pham HQ; Rezaeian I; Angelov D; Ngom A; Rueda L; Rogan PK
F1000Res; 2016; 5():2124. PubMed ID: 28620450
[TBL] [Abstract][Full Text] [Related]
17. Development and Validation of a Machine Learning Model to Explore Tyrosine Kinase Inhibitor Response in Patients With Stage IV EGFR Variant-Positive Non-Small Cell Lung Cancer.
Song J; Wang L; Ng NN; Zhao M; Shi J; Wu N; Li W; Liu Z; Yeom KW; Tian J
JAMA Netw Open; 2020 Dec; 3(12):e2030442. PubMed ID: 33331920
[TBL] [Abstract][Full Text] [Related]
18. Molecular docking and machine learning analysis of Abemaciclib in colon cancer.
Liñares-Blanco J; Munteanu CR; Pazos A; Fernandez-Lozano C
BMC Mol Cell Biol; 2020 Jul; 21(1):52. PubMed ID: 32640984
[TBL] [Abstract][Full Text] [Related]
19. Biomarker identification for statin sensitivity of cancer cell lines.
Raghu VK; Beckwitt CH; Warita K; Wells A; Benos PV; Oltvai ZN
Biochem Biophys Res Commun; 2018 Jan; 495(1):659-665. PubMed ID: 29146185
[TBL] [Abstract][Full Text] [Related]
20. Time-dependent AI-Modeling of the anticancer efficacy of synthesized gallic acid analogues.
Sherin L; Sohail A; Shujaat S
Comput Biol Chem; 2019 Apr; 79():137-146. PubMed ID: 30818108
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
